1 Karapanayiotides T, Meuli R, Devuyst G, et al. Postcarotid endarterectomy hyperperfusion or reperfusion syndrome. Stroke, 2005, 36: 21-26
[2]
2 Suga Y, Ogasawara K, Saito H, et al. Preoperative cerebral haemodynamic impairment and reactive oxygen species produced during carotid endarterectomy correlate with development of postoperative cerebral hyperperfusion. Stroke, 2007, 38: 2712-2717
[3]
3 Danton G H, Dietrich W D. Inflammatory mechanisms after ischemia and stroke. J Neuropathol Exp Neurol, 2003, 62: 127-136
[4]
4 Jean W C, Spellman S R, Nussbaum E S, et al. Reperfusion injury after focal cerebral ischemia: the role of inflammation and the therapeutic horizon. Neurosurgery, 1998, 43: 1382-1396
[5]
5 Huang J, Upadhyay U M, Tamargo R J. Inflammation in stroke and focal cerebral ischemia. Surg Neurol, 2006, 66: 232-245
7 Masuda T, Sato K, Noda C, et al. Protective effect of urinary trypsin inhibitor on myocardial mitochondria during hemorrhagic shock and reperfusion. Crit Care Med, 2003, 31: 1987-1992
[8]
8 Kim S J, Yoo K Y, Jeong C W, et al. Urinary trypsin inhibitors afford cardioprotective effects through activation of PI3K-Akt and ERK signal transduction and inhibition of p38 MAPK and JNK. Cardiology, 2009, 114: 264-270
[9]
9 Ren B, Wu H, Zhu J, et al. Ulinastatin attenuates lung ischemia-reperfusion injury in rats by inhibiting tumor necrosis factor. Transplant Proc, 2006, 38: 2777-2779
[10]
10 Xu L, Ren B, Li M, et al. Ulinastatin suppresses systemic inflammatory response following lung ischemia-reperfusion injury in rats. Transplant Proc, 2008, 40: 1310-1311
[11]
11 Wu Y J, Ling Q, Zhou X H, et al. Urinary trypsin inhibitor attenuates hepatic ischemia-reperfusion injury by reducing nuclear factor-kappa B activation. Hepatobiliary Pancreat Dis Int, 2009, 8: 53-58
[12]
12 Chen C C, Liu Z M, Wang H H, et al. Effects of ulinastatin on renal ischemia-reperfusion injury in rats. Acta Pharmacol Sin, 2004, 25: 1334-1340
[13]
21 Herrmann M, Curio N, Jost S, et al. Release of biochemical markers of damage to neuronal and glial brain tissue is associated with short and long term neuropsychological outcome after traumatic brain injury. J Neurol Neurosurg Psychiatry, 2001, 70: 95-100
[14]
22 Herrmann M, Jost S, Kutz S, et al. Temporal profile of release of neurobiochemical markers of brain damage after traumatic brain injury is associated with intracranial pathology as demonstrated in cranial computerized tomography. J Neurotrauma, 2000, 17: 113-122
24 Pennekamp C W, Immink R V, Moll F L, et al. Differential effect of phenylephrine and ephedrine on cerebral haemodynamics before carotid cross-clamping during carotid endarterectomy. Brit J Anaesth, 2012, 109: 831-833
[17]
13 Yu J R, Yan S, Liu X S, et al. Attenuation of graft ischemia-reperfusion injury by urinary trypsin inhibitor in mouse intestinal transplantation. World J Gastroenterol, 2005, 21: 1605-1609
[18]
14 Yano T, Anraku S, Nakayama R, et al. Neuroprotective effect of urinary trypsin inhibitor against focal cerebral ischemia-reperfusion injury in rats. Anesthesiology, 2003, 98: 465-473
[19]
15 Koga Y, Fujita M, Tsuruta R, et al. Urinary trypsin inhibitor suppresses excessive superoxide anion radical generation in blood, oxidative stress, early inflammation, and endothelial injury in forebrain ischemia/reperfusion rats. Neurol Res, 2010, 32: 925-932
[20]
16 Schell R M, Cole D J. Cerebral monitoring: jugular venous oximetry. Anesth Analg, 2000, 90: 559-566
[21]
17 Moritz S, Kasprzak P, Woertgen C, et al. The accuracy of jugular bulb venous monitoring in detecting cerebral ischemia in awake patients undergoing carotid endarterectomy. J Neurosurg Anesthesiol, 2008, 20: 8-14
19 Polidori M C, Cherubini A, Stahl W, et al. Plasma carotenoid and malondialdehyde levels in ischemic stroke patients: relationship to early outcome. Free Radic Res, 2002, 36: 265-268
[24]
20 Wunderlich M T, Ebert A D, Kratz T, et al. Early neurobehavioral outcome after stroke is related to release of neurobiochemical markers of brain damage. Stroke, 1999, 30: 1190-1195
